Excogitātor
A distinct human presence is becoming scarce.
Veni, vidi, cogitavi
Dr. Shayne Heffernan Ph.D.
Every financial revolution has changed the speed and the surface of finance without changing its substance. Debt cycles still overshoot. Inflation still compounds. Bubbles still form around the new thing while the old rules keep applying. What is different this time is that intelligence itself has become abundant, and everything abundant gets cheap. The scarce thing now is a distinct human presence: judgement shaped by real consequence, taste built over decades, and the willingness to care about a question for longer than is efficient.
I write about that gap most days, and I build in it the rest of the time. Forty years across capital markets, venture capital and emerging technology, and the part that still cannot be automated is the judgement about which question was worth asking. Everything below is published at Live Trading News, wrapped in post-quantum cryptography and anchored on chain at the moment it goes out. The text cannot be altered. Change a word and it is re-signed and re-stamped, and the chain records the new time, so every version and every date stands permanently on the record.
The build-out, the quantum timeline, and what any of it is actually for.
Judgement, independence, and staying non-fungible in an AI world.
Stocks, macro, ramblings and the KXCO build.
Healthspan science, and separating the evidence from the sales pitch.
Food, travel, sport, and the unoptimised parts that refill the well.
Thinking is not a metaphor sitting on top of frequency. It is frequency, organised, across four layers that are electrical, chemical, physical and biological. A companion to The Invisible Symphony that ranks frequency pollution by the quality of the human data behind it, noise first and radiofrequency third, then turns to the part you control: what education, exercise, blood pressure, hearing, sleep, diet and purpose have actually proved about cognitive longevity.
A four-session week decides more than a print. Oracle reports after the close on Thursday 10 September, PPI lands that morning and CPI on Friday, with the ECB in between and the FOMC eight days out. Oracle is the last hyperscaler of the cycle and the widest value gap on the KXCO Ontology Live Analyst Outlook layer: a $457bn market value under a $638bn contracted backlog. Here is the calendar, the graph behind it, the levels and the book.
Eight molecules carry an FDA label. Six carry a nonbinding committee vote. The gray market sells the second as though it were the first. A field report on the longevity pipeline, the capital behind it, and the listed names that matter.
Capability is becoming abundant and everything abundant gets cheap. What does not get cheap is the person who has to sign, and they can only carry what they can see. Four conditions follow from that, and four independent authorities reached the first of them last month without knowing it.
Almost no company can say what cryptography actually runs inside its own software, and auditors have started asking. KXCO publishes five free packages that find it, replace it with the NIST post-quantum standards, and fail the build when someone gets it wrong.
Twenty FDA approval actions so far in 2026, eight of them inside a sixteen-day window in August. A first-in-class RAS inhibitor that doubled survival in pancreatic cancer, an oral GLP-1 cleared in fifty days, a first gene therapy for GSDIa, and seven AI platforms with nine assets in humans and nothing yet approved.
